BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35365379)

  • 1. Identification of genetic mutations of cutaneous squamous cell carcinoma using whole exome sequencing in non-Caucasian population.
    Lee SY; Lee M; Yu DS; Lee YB
    J Dermatol Sci; 2022 May; 106(2):70-77. PubMed ID: 35365379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic progression for local invasion of cutaneous squamous cell carcinoma from the superficial to the deep portion.
    Hwang HW; Shin HT; An HY; Byun JW
    Int J Cancer; 2024 Aug; 155(3):532-544. PubMed ID: 38739001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
    Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
    Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis.
    South AP; Purdie KJ; Watt SA; Haldenby S; den Breems N; Dimon M; Arron ST; Kluk MJ; Aster JC; McHugh A; Xue DJ; Dayal JH; Robinson KS; Rizvi SH; Proby CM; Harwood CA; Leigh IM
    J Invest Dermatol; 2014 Oct; 134(10):2630-2638. PubMed ID: 24662767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-Exome Sequencing Validates a Preclinical Mouse Model for the Prevention and Treatment of Cutaneous Squamous Cell Carcinoma.
    Knatko EV; Praslicka B; Higgins M; Evans A; Purdie KJ; Harwood CA; Proby CM; Ooi A; Dinkova-Kostova AT
    Cancer Prev Res (Phila); 2017 Jan; 10(1):67-75. PubMed ID: 27923803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
    Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
    Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA expression as a risk factor for metastases of cutaneous squamous-cell carcinoma in organ- transplant recipients.
    de Jong E; Quint KD; El Ghalbzouri A; Verdijk RM; Goeman JJ; Heidt S; Claas FHJ; de Fijter JW; Genders RE; Vermeer MH; Bouwes Bavinck JN
    Hum Immunol; 2023 Mar; 84(3):208-213. PubMed ID: 36621381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational landscape of aggressive cutaneous squamous cell carcinoma.
    Pickering CR; Zhou JH; Lee JJ; Drummond JA; Peng SA; Saade RE; Tsai KY; Curry JL; Tetzlaff MT; Lai SY; Yu J; Muzny DM; Doddapaneni H; Shinbrot E; Covington KR; Zhang J; Seth S; Caulin C; Clayman GL; El-Naggar AK; Gibbs RA; Weber RS; Myers JN; Wheeler DA; Frederick MJ
    Clin Cancer Res; 2014 Dec; 20(24):6582-92. PubMed ID: 25303977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
    Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
    JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Genomic Landscape of Actinic Keratosis.
    Thomson J; Bewicke-Copley F; Anene CA; Gulati A; Nagano A; Purdie K; Inman GJ; Proby CM; Leigh IM; Harwood CA; Wang J
    J Invest Dermatol; 2021 Jul; 141(7):1664-1674.e7. PubMed ID: 33482222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
    Levine DE; Karia PS; Schmults CD
    JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate and Characteristics of Incompletely Excised Cutaneous Squamous Cell Carcinoma: A Dermatological Daily Practice Multicenter Prospective Cohort Study.
    van Lee CB; Kouloubis N; Wakkee M; Kelleners-Smeets NWJ; Nellen RGL; van Rengen A; de Vijlder HC; Wijne LCC; Nijsten T; van den Bos RR
    Dermatol Surg; 2022 Dec; 48(12):1269-1273. PubMed ID: 36194767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-Exome Sequencing Could Distinguish Primary Pulmonary Squamous Cell Carcinoma From Lung Metastases in Individuals With Cervical Squamous Cell Carcinoma.
    Li L; Song Q; Cao D; Jiao Y; Yuan G; Song Y
    Pathol Oncol Res; 2022; 28():1610325. PubMed ID: 35645619
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Kdm6a and Trp53 Deficiency Drives the Development of Squamous Cell Skin Cancer in Mice.
    Shea LK; Akhave NS; Sutton LA; Compton LA; York C; Ramakrishnan SM; Miller CA; Wartman LD; Chen DY
    J Invest Dermatol; 2023 Feb; 143(2):232-241.e6. PubMed ID: 36055401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.
    Oberholzer PA; Kee D; Dziunycz P; Sucker A; Kamsukom N; Jones R; Roden C; Chalk CJ; Ardlie K; Palescandolo E; Piris A; MacConaill LE; Robert C; Hofbauer GF; McArthur GA; Schadendorf D; Garraway LA
    J Clin Oncol; 2012 Jan; 30(3):316-21. PubMed ID: 22067401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas.
    Campos MA; Macedo S; Fernandes MS; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32640663
    [No Abstract]   [Full Text] [Related]  

  • 18. Cumulative incidence and timing of subsequent cutaneous squamous cell carcinomas stratified for patients with organ transplantation and hematologic malignancies: A nationwide cohort study.
    Eggermont CJ; Hollestein LM; Hollatz A; Louwman M; Mooyaart AL; Nijsten T; Wakkee M
    J Am Acad Dermatol; 2024 Mar; 90(3):530-536. PubMed ID: 37871807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.
    Campos MA; Macedo S; Fernandes M; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
    J Am Acad Dermatol; 2019 Mar; 80(3):660-669.e6. PubMed ID: 30165166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
    Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.